Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients With SARS-CoV-2 (COVID-19) Infection

Clinical trial NCT04978051 · COMPLETED

Trial details

NCT number: NCT04978051
Sponsor: Sebastian Videla
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2021-04-12
Primary completion: 2021-11-30
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.